| skos:altLabel | - intellectual property
- reported
- gene editing
- CRISPR-Cas9
- Type II
- Clustered Regularly Interspaced Short Palindromic Repeats
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- he CRISPR/Cas (clustered regularly interspaced short palindromic repeat/CRISPRassociated protein (e.g. CRISPR/Cas9)
- (CRISPR)/Cas9
- CRISP gene editing technology
- CRISPER/Cas9
- CRISPR
- CRISPR Cas9 genome editing
- CRISPR RNA
- CRISPR System
- CRISPR gene editing
- CRISPR gene-editing system
- CRISPR locus
- CRISPR screens
- CRISPR system
- CRISPR technology
- CRISPR#C2c2
- CRISPR#Cas12a (formerly Cpf1)
- CRISPR#Cas13_(formerly_C2c2)
- CRISPR#Cas13a
- CRISPR#Genome_engineering
- CRISPR-CAS
- CRISPR-Cas
- CRISPR-Cas systems
- CRISPR-Cas13
- CRISPR-Cas9 gene editing
- CRISPR-Cas9 system
- CRISPR/Cas
- CRISPR/Cas system
- CRISPR/Cas9
- CRISPR/Cas9 gene editing
- CRISPR/Cas9.
- CRISPRi
- CRISPR–Cas3 gene editing
- CRISPR–Cas9
- CRSPR
- Cas13
- Crisper
- Crispr-Cas12e, a, or b
- The CRISPR Pioneers
- The CRISPR System
- crRNA
- publish results
- type II adaptive immune systems
- Clustered Regulatory Interspaced Short Palindromic Repeat (CRISPR)
- clustered regularly interspaced short palindrome repeats (CRISPR)
- clustered regularly interspaced short palindromic repeats
|